Publikationen von Lutz W. Kracht

Galldiks, N.; Ullrich, R.; Schroeter, M.; Fink, G. R.; Kracht, L. W.: Volumetry of [11C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme. European Journal of Nuclear Medicine and Molecular Imaging 37 (1), S. 84 - 92 (2010)

Nakamura, H.; Strong, A. J.; Dohmen, C.; Sakowitz, O. W.; Vollmar, S.; Sue, M.; Kracht, L.; Hashemi, P.; Bhatia, R.; Yoshimine, T. et al.; Dreier, J. P.; Dunn, A. K.; Graf, R.: Spreading depolarizations cycle around and enlarge focal ischaemic brain lesions. Brain 133 (7), S. 1994 - 2006 (2010)

Ullrich, R.; Kracht, L.; Brunn, A.; Herholz, K.; Frommolt, P.; Miletic, H.; Deckert, M.; Heiss, W.-D.; Jacobs, A. H.: Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. Journal of Nuclear Medicine 50 (12), S. 1962 - 1968 (2009)

Galldiks, N.; Ullrich, R.; Schroeter, M.; Fink, G. R.; Kracht, L. W.: Imaging biological activity of a glioblastoma treated with an individual patient-tailored, experimental therapy regimen. Journal of Neuro-Oncology 93 (3), S. 425 - 430 (2009)

Backes, H.; Ullrich, R.; Neumaier, B.; Kracht, L.; Wienhard, K.; Jacobs, A. H.: Non-invasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high grade glioma. European Journal of Nuclear Medicine and Molecular Imaging 36 (12), S. 1960 - 1967 (2009)

Kobe, C.; Kracht, L. W.; Timmermann, L.; Bachmann, J.; Schmidt, M. C.: Perrault Syndrome with progressive nervous system involvement. Clinical Nuclear Medicine 33 (12), S. 922 - 924 (2008)

Hilker, R.; Voges, J.; Weber, T.; Kracht, L. W.; Roggendorf, J.; Baudrexel, S.; Hoevels, M.; Sturm, V.; Heiss, W.-D.: STN-DBS activates the target area in Parkinson disease. An FDG-PET study. Neurology 71 (10), S. 708 - 713 (2008)

Beyer, T.; Pietrzyk, U.; Knoess, C.; Vollmar, S.; Wienhard, K.; Kracht, L.; Bockisch, A.; Maderwad, S.; Kuhl, H.; Fitzek, M.: Multi-modality imaging of uveal melanomas using combined PET/CT, high-resolution PET and MR imaging. Nuklearmedizin-Nuclear Medicine 47 (2), S. 73 - 79 (2008)

Fujiwara, E.; Brand, M.; Kracht, L.; Kessler, J.; Diebel, A.; Netz, J.; Markowitsch, H. J.: Functional retrograde amnesia: a multiple case study. Cortex 44 (1), S. 29 - 45 (2008)

Lehnhardt, F.-G.; Horvath, R.; Ullrich, R.; Kracht, L.; Sobesky, J.; Möller-Hartmann, W.; Jacobs, A. H.; Haupt, W. F.: Altered cerebral glucose metabolism in a family with clinical features resembling mitochondrial neurogastrointestinal encephalomyopathy syndrome in association with multiple mitochondrial DNA deletions. Archives of Neurology 65 (3), S. 407 - 411 (2008)

Ullrich, R.; Backes, H.; Li, H.; Kracht, L.; Miletic, H.; Kesper, K.; Neumaier, B.; Heiss, W.-D.; Wienhard, K.; Jacobs, A. H.: Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma. Clinical Cancer Research 14 (7), S. 2049 - 2055 (2008)

Ullrich, R. T.; Kracht, L. W.; Jacobs, A. H.: Neuroimaging in patients with gliomas. Seminars in Neurology 28 (4), S. 484 - 494 (2008)

Rueger, M. A.; Kracht, L. W.; Hilker, R.; Thiel, A.; Sobesky, J.; Winkeler, A.; Thomas, A. V.; Heneka, M. T.; Graf, R.; Herholz, K. et al.; Heiss, W.-D.; Jacobs, A. H.: Role of in vivo imaging of the central nervous system for developing novel drugs. Quarterly Journal of Nuclear Medicine and Molecular Imaging 51 (2), S. 164 - 181 (2007)

Rueger, M. A.; Kracht, L.; Thiel, A.; Hilker, R.; Herholz, K.; Winkeler, A.; Thomas, V. A.; Heneka, M.; Sobesky, J.; Graf, R. et al.; Heiss, W.-D.; Jacobs, A. H.: Developing novel drugs by in vivo imaging of the CNS. Quarterly Journal of Nuclear Medicine and Molecular Imaging 51 (2), S. 164 - 181 (2007)

Galldiks, N.; Kracht, L. W.; Burghaus, L.; Thomas, A.; Jacobs, A. H.; Heiss, W.-D.; Herholz, K.: Use of C-11-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. European Journal of Nuclear Medicine and Molecular Imaging 33 (5), S. 516 - 524 (2006)

Thiel, A.; Schumacher, B.; Wienhard, K.; Gairing, S.; Kracht, L. W.; Wagner, R.; Haupt, W. F.; Heiss, W.-D.: Direct demonstration of transcallosal disinhibition in language networks. Journal of Cerebral Blood Flow and Metabolism 26 (9), S. 1122 - 1127 (2006)

Jacobs, A. H.; Thomas, A.; Kracht, L. W.; Li, H. F.; Dittmar, C.; Garlip, G.; Galldiks, N.; Klein, J. C.; Sobesky, J.; Hilker, R. et al.; Vollmar, S.; Herholz, K.; Wienhard, K.; Heiss, W.-D.: F-18-fluoro-L-thymidine and C-11-methylmethionine as markers of increased transport and proliferation in brain tumors. Journal of Nuclear Medicine 46 (12), S. 1948 - 1958 (2005)

Lange, C.; Kracht, L.; Herholz, K.; Sachsse, U.; Irle, E.: Reduced glucose metabolism in temporo-parietal cortices of women with borderline personality disorder. Psychiatry Research-Neuroimaging 139 (2), S. 115 - 126 (2005)

Dohmen, C.; Bosche, B.; Galldiks, N.; Kracht, L.; Sobesky, J.; Graf, R.; Heiss, W.-D.: Severity of ischemia determines space-occupying brain edema after middle cerebral artery infarction. Stroke 36 (2), S. 440 - 440 (2005)

Jacobs, A. H.; Kracht, L. W.; Gossmann, A.; Rüger, M.A.; Thomas, A.V.; Thiel, A.; Herholz, K.: Imaging in neurooncology. NeuroRx 2 (2), S. 333 - 347 (2005)